CurvaFix Receives FDA 510(k) Clearance for CurvaFix Rodscrew Company’s Innovative Curved Device to aid Orthopedic Trauma Surgery

CurvaFix

BELLEVUE, Wash., March 05, 2019 (GLOBE NEWSWIRE) — CurvaFix, Inc., a developer of medical devices to repair bone fractures in orthopedic trauma patients, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the CurvaFix® Intramedullary Rodscrew. CurvaFix’s patented solution has the potential to improve outcomes and enable a less invasive approach in…

Read More

Vystar Debuts Enhanced RxAir® UV Light Air Purifiers to Fight Flu, Colds & Airborne Germs

Vystar Corp.

WORCESTER, Mass., Jan. 28, 2019 (GLOBE NEWSWIRE) — Vystar Corp. (OTC Market: VYST) announced today that new and improved RxAir® UV Light Air Purifiers are now available to combat cold, flu and other airborne germs that are more pervasive during the winter.  Vystar acquired RxAir approximately nine months ago and immediately began upgrading the air purifiers to improve performance and…

Read More

CORRECTING and REPLACING – Aurora Spine Announces New Patent for Its Minimally Invasive Spinal Implants Allowed by the United States Patent Office

Aurora Spine Corporation

CARLSBAD, Calif., Jan. 23, 2019 (GLOBE NEWSWIRE) — In a release issued under the same headline earlier today by Aurora Spine Corporation (TSXV: ASG) please note that “Expendable Interspinous Device” has been changed to “Expandable Interspinous Device” in the first paragraph. The corrected release follows: Aurora Spine Corporation (TSXV: ASG) announced today the issuance by the United States Patent and Trademark Office (USPTO) of United States…

Read More

New report: Are prescriptions contributing to the opioid crisis? Canadians are taking increased doses despite national guidelines

Reformulary Group

TORONTO, Jan. 22, 2019 (GLOBE NEWSWIRE) — Reformulary Group, a Canadian healthcare technology company, today released a report on opioid prescribing in Canada. The report analyzes the data of over six million prescription Canadians that submitted a drug claim from 2013 to 2017 to address the impact of prescription opioids on the health and safety of all Canadians. The report,…

Read More

Q BioMed Announces Strategic Partnership with SRI International for Formulation and Preclinical Development of QBM-001 for Pediatric Nonverbal Disorder in Autistic Children

Collaboration with SRI Provides QBioMed Expertise in Formulation Development and Preclinical Work in Autism, as well as CMC and Manufacturing capability NEW YORK, December 12, 2018 — Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company, is pleased to announce a collaborative agreement with SRI International to provide formulation development, preclinical development, and early clinical manufacturing of QBM-001, in support…

Read More

Alliqua BioMedical, Inc. (NASDAQ: ALQA) Skyrockets 168% After Announcing Plans to Spin-Off and Merger Contract Manufacturing Business With TO Pharmaceuticals, LLC

Alliqua BioMedical, Inc. (NASDAQ: ALQA) operates as a custom manufacturer within the medical device, cosmetics, OTC markets. Shares of the medical manufacturer are skyrocketing 168.08%, through early trading on Wednesday, November 28, 2018. Over the past three months, Alliqua BioMedical, Inc. has seen average daily volume of 13,278 shares. However, volume of 15.06 million shares or dollar volume of $59.94…

Read More

Q BioMed Inc Announces Acquisition of Cancer Pain Drug Metastron™ from GE Healthcare

Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Countries in Which Metastron™ is Already Registered and Approved for Sale NEW YORK, November 28, 2018 — Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company, is pleased to announce that it has entered into agreement to acquire the metastatic skeletal cancer palliation drug, Metastron™,…

Read More

Molecular Biology Kits and Reagents and Enzymes Market Analysis, Growth and Demand, 2022

Molecular biology kits and reagents and enzymes market was valued at $4,928.3 million in 2015 and it is expected to grow at a CAGR of 17.2% during 2016 – 2022. The molecular biology kits and reagents and enzymes market is growing due to increasing geriatric population, increasing prevalence of infectious diseases, and growing cases with genetic disorders. In addition, increasing…

Read More

Telemedicine Market Scenario, Leading Players, Segments Analysis and Growth Drivers to 2022

The global telemedicine market is growing at a significant rate, due to growing geriatric population, increasing healthcare cost, increasing government funding and grants for telemedicine, and increas… The global telemedicine market is growing at a significant rate, due to growing geriatric population, increasing healthcare cost, increasing government funding and grants for telemedicine, and increasing prevalence of chronic and lifestyle associated…

Read More

Population Health Management Market Size, status, Revenue, Growth Rate and Future Analysis

The global population health management market was valued at $11,114.4 million in 2015, and it is expected to grow at a CAGR of 23.3% during 2016-2022. The global population health management market is growing at a significant rate, due to growing geriatric population, regulatory mandate under the Affordable Care Act (ACA), and increasing prevalence of chronic and lifestyle associated diseases.…

Read More